Is the pharmaceutical industry’s preoccupation with the monotherapy drug model stifling the development of effective new drug therapies?
Crossref DOI link: https://doi.org/10.1007/s10787-018-0488-7
Published Online: 2018-05-07
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cock, Ian Edwin
Text and Data Mining valid from 2018-05-07
Article History
Received: 1 March 2018
Accepted: 21 April 2018
First Online: 7 May 2018